GE HealthCare (GEHC) and Masimo (MASI) announced a joint agreement to integrate Masimo Signal Extraction Technology SET pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. Portrait Mobile is built as an Internet of Medical Things IoM platform, using the latest cloud native technology to provide an end-to-end experience for wearable continuous monitoring. By integrating Masimo SET clinicians will be able to leverage Masimo’s clinically proven Measure-through Motion and Low Perfusion oxygen saturation SpO2 measurement technology to noninvasively detect and continuously monitor changes in patient status. The agreement follows Portrait Mobile’s 510(k) clearance from the U.S. FDA in August 2023. ..”We are excited to build on our collaboration with GE HealthCare by providing integrated solutions to help our customers and optimize patient care,” said Bilal Muhsin, Chief Operating Officer at Masimo. “Through our expansion into mobile, wireless technologies, we are proud to incorporate Masimo SET(R) pulse oximetry into the Portrait Mobile monitoring solution.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MASI:
- Masimo price target lowered to $105 from $150 at BTIG
- Masimo price target lowered to $81 from $110 at Wells Fargo
- Raymond James downgrades Masimo on ‘more muted growth profile’
- Masimo downgraded to Market Perform from Outperform at Raymond James
- Masimo cuts FY23 EPS view to $2.85-$3.05 from $3.35-$3.55